Advancing combination therapy for recurrent glioblastoma. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Advancing combination therapy for recurrent glioblastoma.

Adela Wu, Michael Lim

Author Information

Adela Wu: Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA.
Michael Lim: Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA. mklim@stanford.edu. ORCID

PMID: 37188784 DOI: 10.1038/s41591-023-02350-3

No abstract text available.

Nat Commun. 2021 Jun 29;12(1):4031 [PMID: 34188042]
JAMA Oncol. 2020 Jul 1;6(7):1003-1010 [PMID: 32437507]
Neuro Oncol. 2023 Jan 5;25(1):123-134 [PMID: 35419607]
Neuro Oncol. 2022 Nov 2;24(11):1935-1949 [PMID: 35511454]
Nat Med. 2023 Jun;29(6):1370-1378 [PMID: 37188783]
Hum Gene Ther. 2005 Aug;16(8):996-1005 [PMID: 16076257]
Cell. 2017 Sep 7;170(6):1109-1119.e10 [PMID: 28886381]
J Clin Oncol. 2018 May 10;36(14):1419-1427 [PMID: 29432077]
Neuro Oncol. 2020 Nov 26;22(11):1568-1579 [PMID: 32598442]

Humans

Glioblastoma

Neoplasm Recurrence, Local

Chronic Disease

Journal Article